Upcoming Conferences 

CSRO 2019 State Society Advocacy Conference
September 13 - 14, 2019
Westin Chicago O'Hare
Rosemont, IL
ACR 2019 Annual Meeting
November 8 - 13, 2019

Atlanta, GA
CSRO 2020 Fellows Conference
March 6 - 7, 2020
InterContinental Mark Hopkins
San Francisco, CA

Latest News 

CMS Issues Final Rule Affecting Patient Access and Prescription Drug Affordability The Centers for Medicare and Medicaid (CMS) published its “Medicare Advantage and Part D Drug Pricing Final Rule” in May which seeks to increase drug pricing transparency, lower prescription drug costs, and improve patient medication adherence.
CSRO President Testifies Before Congress Last week, the House Energy and Commerce Subcommittee on Health held a hearing entitled: “Improving Drug Pricing Transparency and Lowering Prices for American Consumers.” CSRO President, Dr. Madelaine Feldman, was invited to represent the Alliance for Specialty Medicine and deliver testimony at the hearing.
FDA Releases Final Guidance on Interchangeable Biosimilars Last week, the FDA released its long anticipated final guidance for industry on “Considerations in Demonstrating Interchangeability with a Reference Product.”
CSRO offers Federal Policy Virtual “Town Hall” to Rheumatology Community The gridlock immobilizing Congress has slowed the progress of health care legislation significantly, but it has not stopped key Federal agencies from proposing and implementing policies that have a far reaching impact on the practice of rheumatology.
CSRO Comments on Proposed Rule to Eliminate Safe Harbor Protections for Prescription Drug Rebates The Coalition of State Rheumatology Organizations (CSRO) recently submitted comments on the Department of Health and Human Services (HHS) proposed rule amending the Federal anti-kickback statute.

Coalition of State Rheumatology Organizations. The Coalition of State Rheumatology Organization (CSRO)
is comprised of over 40 state and regional professional rheumatology societies whose mission is to advocate for excellence in the field of rheumatology, ensuring access to the highest quality care for the management of rheumatologic and musculoskeletal disease.